Navigation Links
Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant

Ras Al Khaimah, UAE (PRWEB) March 29, 2013

Grace Century, FZ LLC, specializing in “game-changing” life science and health related private equity projects, recently announced the appointment of Yeow Fook (Eddie) Leong to their Advisory Board as Chief Compliance Officer. Leong brings decades of leadership, problem solving, and project leadership experience from Exxon Mobile.

Leong holds his Bachelors of Engineering from the University of Tokyo and is fluent in 5 languages. His international experience--which spans across 4 continents--along with his deep management background, has given him a keen vision of thinking “outside the box.”

Leong’s responsibilities with Grace Century will include due-diligence of potential new projects, ongoing oversight of accepted projects, and marketing coordination of existing projects in Asia and emerging markets. Like Grace Century, Leong will also take an equity participation in all projects, furthering his desire to bring all of Grace Century’s projects full-circle.

Grace Century President, Scott Wolf says, “I have yet to work with anyone who brings in the kind of energy, determination, and pragmatic stance that Eddie Leong brings to our process. He is truly an asset to Grace Century.”

Wolf further adds, “Eddie Leong realizes that all projects have benchmarks that must be met. When these benchmarks are met, they are then further analyzed to determine the areas that can be improved upon. And if these benchmarks are not met, an investigation and analytical review is conducted to determine why--so that alternative (better) steps can be quickly introduced. Simply put: Failure is never an option with Eddie Leong.”


About Grace Century
Grace Century, FZ LLC is an international research and private equity consulting company located in Ras Al Khaimah, United Arab Emirates (UAE). Grace Century specializes in conducting due-diligence for its group of international members, as well as assisting firms in the development and execution of “game changing” ideas in the life sciences and healthcare technology industries. Utilizing its vast network, Grace Century assists in capital formation, market penetration, joint ventures, and brand development.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
2. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
3. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
4. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
5. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
6. Agendia Signs Contract with Blue Shield of California
7. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
8. Volition Signs Collaboration Agreement With Abcodia
9. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
10. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
11. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
Post Your Comments:
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology:
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:10/29/2015)... Oct. 29, 2015   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Association (MHTA) as one of only three finalists for ... – Small and Growing" category. The Tekne Awards honor ... shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):